To view posters presentations of study results, click here.

PUBLICATIONS (newest to oldest)
​Plesons M, Forman E, McDowell EC, Krakower D, Amico KR, Groves AK, Roth A, Bartholomew TS. Staff Perspectives on Implementation of Long-Acting Injectable Preexposure Prophylaxis at a Low-Barrier Syringe Services Program in Philadelphia, PA. Journal of the International Association of Providers of AIDS Care. 2026 Jan-Dec;25:23259582261420655.  Published online 2026 Feb 11. doi: 10.1177/23259582261420655. PMID: 41671099.
Roth AM, Forman E, Akiba CF, Eger WH, Laurano R, Huffaker SL, Patel SV, Smith J, Lambdin BH, Bazzi AR. HIV services implementation within U.S. syringe services programs: a qualitative exploration. AIDS Patient Care and STDs. Published online 2025 Sept 11. https://doi.org/10.1177/10872914251376934. 
Ward KM, Carrico AW, Vader D, Moore RH, Amico KR, Groves AK, Bellamy SL, Sherman SG, Krakower D, Mazzella S, Roth AM. Implementation of contingency management with women engaging in polysubstance use. Addiction Science & Clinical Practice. 2025;63(20). Published 2025 Aug 8. doi:10.1186/s13722-025-00590-x
Roth AM, Ward KM, McDowell E, Forman E, Amico KR, Bartholomew TS, Krakower D, Vader D, Mazzella S, Carrico AW, Sherman SG, Groves A. "The Simplest Way to Go": An Exploration of Why Women Who Inject Drugs Chose Long-Acting Injectable Cabotegravir Instead of Daily Oral PrEP. AIDS and Behavior. 2025 Dec;29(12):3970-3980. doi: 10.1007/s10461-025-04833-5. Epub 2025 Aug 6. PMID: 40767995; PMCID: PMC12580424.
Roth AM, D'Angelo AK, Gordon D, Cocchiaro B, Lingamoorthy A, Laurano R, Salzman M, Brenner JS, Baston C. Use of a Shoulder-Mounted Wearable Sensor Prototype Designed to Detect Opioid-Related Overdose: A Qualitative User Experience Study. Journal of Medical Internet Research. 2025;27:e73566. Published 2025 Jul 28. doi: 10.2196/73566.
Bazzi AR, Roth AM, Akiba CF, Huffaker SL, Patel SV, Smith J, Laurano R, Orme S, Zarkin GA, Morgan-Lopez A, Lambdin BH. A systems analysis and improvement approach to optimizing syringe services programs' delivery of HIV testing and referrals: Study protocol for a parallel-group randomized controlled trial (SAIA-SSP-HIV). PLoS One. 2025;20(2):e0319340. Published 2025 Feb 25. doi:10.1371/journal.pone.0319340
​Roth AM, Bartholomew TS, Ward KM, Groves A, Mazzella S, Bellamy S, Amico KR, Carrico A, Ironson G, Krakower D. Preferential Initiation of Long-Acting Injectable versus Oral HIV Pre-Exposure Prophylaxis among Women Who Inject Drugs. Clinical Infectious Diseases. 2025;80(3):621-625. Published 2024 Sept 30. doi:10.1093/cid/ciae450.
Roth AM, Ward KM, Hensel DJ, Elliott L, Bennett AS. Exploration of weekly variation in naloxone possession and carriage among people who use opioids in New York City before, during, and after the COVID-19 pandemic. ​PLoS ONE; 2024 19(7): e0307151. Published 2024 July 18. doi: 10.1371/journal.pone.0307151. 
Miley KL, Tran NK, Elopre L, Groves A, Stockman JK, Bazzi AR, Carrico A, Mazzella S, Roth AM+. A Note on Pre-exposure prophylaxis (PrEP) preferences among women who inject drugs. Sex Transm Dis. 2023;50(10):671-674. doi: 10.1097/OLQ.0000000000001768. PMID: 36728264.
Ward KM, Scheim A, Wang J, Cocchiaro B, Singley K, Roth AM. Impact of reduced restrictions on buprenorphine prescribing during COVID-19 among patients in a community-based treatment program. Drug Alcohol Depend Rep. 2022;3:100055. doi:10.1016/j.dadr.2022.100055
​Roth AM, Tran NK, Cocchiaro B, Mitchell AK, Schwartz DG, Hensel DJ, Ataiants J, Brenner J, Yahav I, Lankenau SE. Wearable biosensors have the potential to monitor physiological changes associated with opioid overdose among people who use drugs: A proof-of-concept study in a real-world setting. Drug Alcohol Depend. 2021 Dec 1;229(Pt A):109138. doi: 10.1016/j.drugalcdep.2021.109138. PMID: 34781097; PMCID: PMC8672322.
Felsher M, Dutra K, Monseur B, Roth AM, Latkin C, Falade-Nwulia O. The Influence of PrEP-related stigma and social support on PrEP-Use Disclosure among Women who Inject Drugs and Social Network Members. AIDS and Behavior. 2021 May 20;25(12):3922–3932. doi: 10.1007/s10461-021-03312-x
Felsher M, Ziegler E, Amico KR, Carrico A, Coleman J, Roth AM. “PrEP just isn’t my priority”: Adherence Challenges among Women who Inject Drugs Participating in a Pre-Exposure Prophylaxis (PrEP) Demonstration Project in Philadelphia, PA USA. Social Science & Medicine, 2021 Mar 4;275:113809. doi: 10.1016/j.socscimed.2021.113809
Tran NK, Felsher  MA,  Van  Der  Pol  B,  Bellamy  SL,  McKnight  J,  Roth  AM. Intention to Initiate and Uptake of PrEP among Women Who Injects Drugs in a Demonstration Project: An Application of the Theory of Planned Behavior. AIDS Care.  2021 Jan 23;33(6):746–753. doi: 10.1080/09540121.2021.1874267 
Felsher M, Koku E, Bellamy S, Mulawa M, Roth AM. Predictors of Willingness to Diffuse PrEP Information within Ego-Centric Networks of Women who Inject Drugs. AIDS and Behavior. 2021 Jan 1;25(6):1856–1863. doi: 10.1007/s10461-020-03115-6
   Felsher M, Koku E, Lankenau SE, Brady K, Bellamy S, Roth AM. Motivations for PrEP-Related Interpersonal Communication among Women Who Inject Drugs: A Qualitative Ego-Centric Network Study. Qualitative Health Research. 2021 31(1), 86-99. doi:10.1177/1049732320952740. NIHMSID 1656600.
Roth AM, Tran NK, Felsher MA, Gadegbeku AB, Piecara B, Krakower DS, Bellamy SL, Amico KR, Benitez JA, Van Der Pol B. Integrating HIV pre-exposure prophylaxis with community-based syringe services for women who inject drugs: Results from the Project SHE demonstration study. J Acquir Immune Defic Syndr. 2021;86(3):e61-e70. doi: 10.1097/QAI.0000000000002558. NIHMSID 1641464.
​Roth AM,  Mitchell AK, Mukherjee R, Scheim AI, Ward KM, Lankenau SE. Prevalence and correlates of syringe disposal box use in a Philadelphia neighborhood with high levels of public drug injection. Substance Use & Misuse. 2021;56(5):668-673. doi:10.1080/10826084.2021.1887252
​ Roth AM, Tran NK, Cocchiaro B, Mitchell AK, Schwartz DG, Hensel DJ, Ataiants J, Brenner J, Yahav I, Lankenau SE. Wearable biosensors have the potential to monitor physiological changes associated with opioid overdose among people who use drugs: A proof-of-concept study in a real-world setting. Drug Alcohol Depend. 2021 Dec 1;229(Pt A):109138. doi: 10.1016/j.drugalcdep.2021.109138. PMID: 34781097; PMCID: PMC8672322.
Felsher M, Bellamy S, Piecara B, Van Der Pol B, Laurano R, Roth AM. Applying the Behavioral Model for Vulnerable Populations to Pre-Exposure Prophylaxis Initiation among Women who Inject Drugs. AIDS Education and Prevention. 2020;32(6):486-492. doi:10.1521/aeap.2020.32.6.486
Felsher M, Ziegler E, Smith LR, Sherman SG, Amico KR, Fox R, Madden K, & Roth AM. An Exploration of Pre-Exposure Prophylaxis Initiation among Women who Inject Drugs. Archives of Sexual Behavior.  (2020). https://doi.org/10.1007/s10508-020-01684-0​
Roth AM, Kral AH, Mitchell A, Mukherjee R, Davidson P, Lankenau SE. Overdose Prevention Site Acceptability Among Residents and Businesses Surrounding a Proposed Site in Philadelphia, USA. J Urban Health. 2019;96(3):341-352. doi:10.1007/s11524-019-00364-2 here.
Roth AM, Felsher M, Tran N, Bellamy S, Martinez-Donate A, Krakower D, Szep Z. Drawing from the Theory of Planned Behavior to Understand Pre-Exposure Prophylaxis Intentions among a Diverse Sample of Heterosexuals in High HIV Prevalence Neighborhoods in Philadelphia: An Observational Study. Sexual Health. 2019. doi: 10.1071/SH18081.
Roth AM, Tran N, Piecara BL, Shinefeld J, Brady KB. Pre-Exposure Prophylaxis (PrEP) Awareness is Low among Heterosexual People of Color who Might Benefit from PrEP in Philadelphia. J Prim Care Community Health. 2019(10): 2150132719847383. doi: 10.1177/2150132719847383.
Roth AM, Tran N, Felsher M, Szep Z, Krakower D. Heterosexual men anticipate risk compensatory behaviors with future PrEP initiation: Findings from an exploratory cross-sectional study [published online ahead of print April 1, 2019]. Sex Trans Dis. 2019. doi: 10.1097/OLQ.0000000000001012.
Roth AM, Tran N, Piecara BL, Welles S, Shinefeld J, Brady KA. Factors associated with awareness of pre-exposure prophylaxis for HIV among persons who inject drugs in Philadelphia: National HIV Behavioral Surveillance, 2015 [published online ahead of print September 28, 2018]. AIDS Behav. 2018. doi: 10.1007/s10461-018-2293-0.
Felsher M & Koku E. Explaining HIV Risk Multiplexity: A Social Network Analysis. AIDS Behav. 2018; 22(11):3500-3507. doi: 10.1007/s10461-018-2120-7.
Tran NK, Goldstein ND, & Welles SL. Bias Adjustment Techniques are Underutilized in HIV Sexual Risk Estimation: A Systematic Review. Int J Environ Res Public Health. 2018; 15(8):1696. doi: /10.3390/ijerph15081696.​
Roth AM, Tran NK, Chavis M, & Van Der Pol B. Examining Unmet Needs: A Cross Sectional Study Exploring Knowledge, Attitudes, and Sexually Transmitted Infection Screening Preferences among Persons Who Inject Drugs in Camden, New Jersey. Sex Transm Infect. 2018; 94(8):598-603. doi: 10.1136/sextrans-2017-053498. 
Felsher M, Szep Z, Krakower D, Martinez-Donate A, Tran N, & Roth AM. “I Don't Need PrEP Right Now”: A Qualitative Exploration of the Barriers to PrEP Care Engagement Through the Application of the Health Belief Model. AIDS Education and Prevention. 2018; 30(5), 369-381. doi: 10.1521/aeap.2018.30.5.369.